|
|
|
|
|
|
![]() |
|
Study of Bacterial Enzyme Reveals One Key to
Cancer Cell Survival Behind the Cancer
Headlines® April 25, 2003 An enzyme that helps
disease-causing bacteria withstand attacks by the body's natural defenses turns
out to be a key to human cell survival and growth and may help explain why
cancer cells can multiply unchecked. Leslie B. Poole,
Ph.D., of Wake Forest University Baptist Medical Center said the explanation
begins with the way that bacteria—such as one that causes food poisoning—use
the enzyme to combat hydrogen peroxide. Hydrogen peroxide, best known as hair
bleach or as an antiseptic, is toxic to cells and is one weapon that the body's
white blood cells release in an attempt to kill invaders. Bacteria such as
salmonella use the enzyme, called a peroxiredoxin, to inactivate the hydrogen
peroxide coming from the white blood cells. Writing in the
journal Science, Poole, associate professor of biochemistry, and her
colleagues at Oregon State University describe how the same group of
peroxiredoxin enzymes work differently in people and other mammals. The enzyme
becomes the biochemical switch that keeps the amount of hydrogen peroxide in
the body low, but allows it to increase when it is used for intracellular
signaling. The body's cells
respond to their environment by generating signals to communicate between one
another and between molecules inside the cells, Poole said. "Hydrogen
peroxide is an effective signaling molecule because it is rapidly produced, is
reactive and is easily controlled by antioxidant enzymes," Poole said. The
complex signaling pathways occur in mammals but not in bacteria. What determines
whether hydrogen peroxide acts as a dangerous oxidant or as a signal? The
investigators propose that the peroxiredoxin enzyme controls the floodgates,
keeping resting levels of hydrogen peroxide low, while permitting higher levels
for signaling. After studying the
enzyme using Oregon State's single crystal X-ray diffractometer, Poole and her
colleagues found that related peroxiredoxins have unique structures that have
different shapes depending on whether they are used solely to prevent the flow
of hydrogen peroxide or whether the hydrogen peroxide is also being used for
signaling. They propose that the
enzyme ordinarily keeps the hydrogen peroxide in check, so that no signaling is
produced. When the hydrogen peroxide is needed for signaling, an intracellular
burst of hydrogen peroxide overwhelms the enzyme, switching it off and
permitting the signal. When too much of the enzyme is present, the burst of
hydrogen peroxide can't inactivate all of it, and the signal is blocked. However, Poole said
the bacterial peroxiredoxins—like the ones in salmonella that she has
studied—"are resistant to this inactivation." She explained,
"Because the bacteria don't have the complex signaling pathways present in
mammals, they don't need this ability to turn off the peroxiredoxin." So
the enzyme is always available to eliminate hydrogen peroxide. This discovery may
shed light on human disease processes. For example, Poole and her colleagues
believe peroxiredoxin-regulated signaling may also be related to cancer.
Ordinarily, abnormal cells in the body are programmed to die off, a process
that scientists call apoptosis. In some cancer cells, apoptosis stops working,
which means the cancer cells don't die off. The cancer cells may never get the
signal to die because of the peroxiredoxin enzyme. They found a
correlation between this failure and too much peroxiredoxin, suggesting the two
could be related. SOURCES: Science, April 25, 2003 Wake Forest
University Baptist Medical Center (http://www.wfubmc.edu) DISCLAIMER!Behind the Cancer Headlines (TM) is a service of Willis-Knighton Cancer Center.The articles in Behind the Cancer Headlines (TM) are written by national medical editorsand writers who review current literature and develop timely articles in non-technicallanguage. Sources of information are cited for each article. If you have questions, referto the sources listed or to your physician. Willis-Knighton Cancer Center is notresponsible for content. Articles are updated on Monday, Wednesday, and Friday. This information is provided for information only and is not a substitute for informationfrom or care by a physician. |
|
If you have comments, questions or problems with this website, please contact: webmaster@wkhs.com Willis-Knighton Health System. All rights reserved. |
|
| Home | Staff | Equipment | Patient Info | Links/Clinical Trials | Treatments | News Articles | Directions/Map | Center for IMRT |